129 related articles for article (PubMed ID: 6839558)
1. Peritoneal pharmacokinetics of gentamicin in man.
de Paepe M; Lameire N; Belpaire F; Bogaert M
Clin Nephrol; 1983 Mar; 19(3):107-9. PubMed ID: 6839558
[TBL] [Abstract][Full Text] [Related]
2. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
[TBL] [Abstract][Full Text] [Related]
3. A prospective randomized comparison of single versus multidose gentamicin in the treatment of CAPD peritonitis.
Lye WC; Wong PL; van der Straaten JC; Leong SO; Lee EJ
Adv Perit Dial; 1995; 11():179-81. PubMed ID: 8534699
[TBL] [Abstract][Full Text] [Related]
4. Serum and dialyzate concentrations of intraperitoneal cephalothin in patients undergoing continuous ambulatory peritoneal dialysis.
Münch R; Steurer J; Lüthy R; Siegenthaler W; Kuhlmann U
Clin Nephrol; 1983 Jul; 20(1):40-3. PubMed ID: 6883818
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and bactericidal activity of a single daily dose of netilmicin in the treatment of CAPD-associated peritonitis.
Anding K; Krumme B; Pelz K; Böhler J; Schollmeyer P
Int J Clin Pharmacol Ther; 1996 Nov; 34(11):465-9. PubMed ID: 8937927
[TBL] [Abstract][Full Text] [Related]
6. Peritonitis in continuous ambulatory peritoneal dialysis: cytokines in peritoneal fluid and blood.
Enríquez J; Klínger J; Arturo JA; Delgado M; Tobar C; Mosquera M
Adv Perit Dial; 2002; 18():177-83. PubMed ID: 12402614
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of intraperitoneal cefazolin and gentamicin in empiric therapy of peritonitis in continuous ambulatory peritoneal dialysis patients.
Tosukhowong T; Eiam-Ong S; Thamutok K; Wittayalertpanya S; Na Ayudhya DP
Perit Dial Int; 2001; 21(6):587-94. PubMed ID: 11783768
[TBL] [Abstract][Full Text] [Related]
8. Unidirectional absorption of gentamicin from the peritoneum during continuous ambulatory peritoneal dialysis.
Somani P; Shapiro RS; Stockard H; Higgins JT
Clin Pharmacol Ther; 1982 Jul; 32(1):113-21. PubMed ID: 7083725
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetics of ceftazidime injected peritoneally in continuous ambulatory peritoneal dialysis].
Ryckelynck JP; Vergnaud M; Hurault de Ligny B; Allouche G; Malbruny B; Morel C
Pathol Biol (Paris); 1986 May; 34(5):328-31. PubMed ID: 3534700
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal fluid concentrations of gentamicin in patients with spontaneous bacterial peritonitis.
Richey GD; Schleupner CJ
Antimicrob Agents Chemother; 1981 Feb; 19(2):312-5. PubMed ID: 7347563
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the epidemiological, clinical and laboratory findings in continuous ambulatory peritoneal dialysis related peritonitis attacks].
Bulut C; Oztürk R; Yilmaz GR; Parpucu H; Irmak H; Kinikli S; Duranay M; Demiröz AP
Mikrobiyol Bul; 2008 Apr; 42(2):255-64. PubMed ID: 18697423
[TBL] [Abstract][Full Text] [Related]
12. MCP-1 levels are elevated in peritonitis fluid from CAPD patients due to secretion by peritoneal macrophages.
Sach M; Loetscher P; Burger JA; Knopf HP; Schollmeyer P; Dobos GJ
Adv Perit Dial; 1995; 11():19-23. PubMed ID: 8534702
[TBL] [Abstract][Full Text] [Related]
13. Mannose binding lectin level and polymorphism in patients on long-term peritoneal dialysis.
Lam MF; Leung JC; Tang CC; Lo WK; Tse KC; Yip TP; Lui SL; Chan TM; Lai KN
Nephrol Dial Transplant; 2005 Nov; 20(11):2489-96. PubMed ID: 16115848
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotyping by flow cytometry of peritoneal fluid of patients with peritonitis on continuous ambulatory peritoneal dialysis.
Enríquez J; Klínger J; Arturo JA; Tobar C; Ceballos O
Adv Perit Dial; 2002; 18():184-7. PubMed ID: 12402615
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-12 and -18 levels in peritoneal dialysate effluent correlate with the outcome of peritonitis in patients undergoing peritoneal dialysis: implications for the Type I/Type II T-cell immune response.
Wang HH; Lin CY
Am J Kidney Dis; 2005 Aug; 46(2):328-38. PubMed ID: 16112053
[TBL] [Abstract][Full Text] [Related]
17. [Peritonitis during continuous ambulatory peritoneal dialysis. Lavage treatment or not? A prospective study].
De Groc F; Rottembourg J; Jacq D; Jarlier V; N'Guyen J; Legrain M
Nephrologie; 1983; 4(1):24-7. PubMed ID: 6843764
[TBL] [Abstract][Full Text] [Related]
18. [Peritonitis in continuous ambulatory peritoneal dialysis. Culture of peritoneal dialysate fluid].
Møller JK; Hagelskjaer LH
Ugeskr Laeger; 1996 Apr; 158(18):2538-41. PubMed ID: 8686007
[TBL] [Abstract][Full Text] [Related]
19. Comparative penetration of amikacin, gentamicin, and penicillin g into exudate fluid in experimental sterile peritonitis.
MacGregor RR
Antimicrob Agents Chemother; 1977 Jan; 11(1):110-3. PubMed ID: 836008
[TBL] [Abstract][Full Text] [Related]
20. Disposition of ceftazidime after intraperitoneal administration in adolescent patients receiving continuous cycling peritoneal dialysis.
Sisterhen LL; Stowe CD; Farrar HC; Blaszak CK; Blaszak RT
Am J Kidney Dis; 2006 Mar; 47(3):503-8. PubMed ID: 16490630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
